Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 6:20 AM ET

Healthcare Equipment and Supplies

Company Overview of Senseonics, Inc.

Company Overview

Senseonics, Inc., a medical device company, engages in the development and commercialization of transformative glucose monitoring products for people with diabetes. The company’s portfolio includes Continuous Glucose Monitoring System, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver for obtaining continuous glucose readings during the 180-day study duration. Its sensor technology is also used to detect other chemical species, such as oxygen, carbon dioxide, pH, nitric oxide, lactate, and anesthetic gases. The company ...

20451 Seneca Meadows Parkway

Germantown, MD 20876-7005

United States

Founded in 1996





Key Executives for Senseonics, Inc.

Chief Executive Officer, President, Consultant and Director
Age: 53
Chief Financial Officer
Age: 61
Vice President of Operations, Quality and Regulatory
Vice President of Clinical Sciences
Compensation as of Fiscal Year 2015.

Senseonics, Inc. Key Developments

Senseonics, Inc. Appoints R. Don Elsey as Chief Financial Officer

Senseonics, Inc. announced the appointment of R. Don Elsey as the company's new Chief Financial Officer. Prior to joining the company, Don served from May 2014 to February 2015 as the CFO of Regado Biosciences. From December 2013 to March 2014, he was the CFO of LifeCell, Inc.

Oxford Finance LLC Announces Closing of $10 Million Senior Secured Term Loan Agreement with Senseonicsc

Oxford Finance LLC has announced the closing of a $10 million senior secured term loan agreement with Senseonics, Inc. Proceeds of the loan will be used to fund the ongoing development of an implantable continuous glucose monitoring system for people with diabetes.

Similar Private Companies By Industry

Company Name Region
Precise Dental Products, Ltd. United States
Boston Scientific Scimed, Inc. United States
MetroSleep Inc. United States
DJO Finance LLC United States
SpineVision, Inc. United States

Recent Private Companies Transactions

Private Placement
August 4, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Senseonics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at